EP1003770A4 - Secreted proteins and polynucleotides encoding them - Google Patents
Secreted proteins and polynucleotides encoding themInfo
- Publication number
- EP1003770A4 EP1003770A4 EP98930279A EP98930279A EP1003770A4 EP 1003770 A4 EP1003770 A4 EP 1003770A4 EP 98930279 A EP98930279 A EP 98930279A EP 98930279 A EP98930279 A EP 98930279A EP 1003770 A4 EP1003770 A4 EP 1003770A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- polynucleotides encoding
- secreted proteins
- secreted
- proteins
- polynucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98588 | 1993-07-28 | ||
| US87871597A | 1997-06-19 | 1997-06-19 | |
| US9858898A | 1998-06-17 | 1998-06-17 | |
| PCT/US1998/012516 WO1998057976A1 (en) | 1997-06-19 | 1998-06-18 | Secreted proteins and polynucleotides encoding them |
| US878715 | 2001-06-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1003770A1 EP1003770A1 (en) | 2000-05-31 |
| EP1003770A4 true EP1003770A4 (en) | 2002-10-30 |
Family
ID=26794899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98930279A Withdrawn EP1003770A4 (en) | 1997-06-19 | 1998-06-18 | Secreted proteins and polynucleotides encoding them |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1003770A4 (en) |
| JP (1) | JP2002513294A (en) |
| AU (1) | AU7970498A (en) |
| CA (1) | CA2294569A1 (en) |
| WO (1) | WO1998057976A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003516734A (en) * | 1999-12-01 | 2003-05-20 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | Cancer-associated antigens and uses thereof |
| JP5504562B2 (en) * | 2006-12-20 | 2014-05-28 | 東レ株式会社 | Cancer detection method |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4798885A (en) * | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
| US5770209A (en) * | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
| US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
| BR9407035A (en) * | 1993-06-29 | 1996-03-12 | Chiron Corp | Fragment of keratinocyte growth factor conjugated therapeutic composition DNA molecule expression vector host cell process to produce fragment of keratinocyte growth factor process for wound healing and process of treatment of hyperproliferative disease of the epidermis |
| US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
| US5708157A (en) * | 1996-07-26 | 1998-01-13 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| US5792628A (en) * | 1997-03-14 | 1998-08-11 | Bowman; Michael | Secreted protein, BA3.1, and polynucleotides encoding same |
-
1998
- 1998-06-18 JP JP50468199A patent/JP2002513294A/en active Pending
- 1998-06-18 WO PCT/US1998/012516 patent/WO1998057976A1/en not_active Ceased
- 1998-06-18 AU AU79704/98A patent/AU7970498A/en not_active Abandoned
- 1998-06-18 EP EP98930279A patent/EP1003770A4/en not_active Withdrawn
- 1998-06-18 CA CA002294569A patent/CA2294569A1/en not_active Abandoned
Non-Patent Citations (5)
| Title |
|---|
| DATABASE EMBL [online] 30 June 1993 (1993-06-30), XP002209843, Database accession no. L20259 * |
| DATABASE EMBL [online] XP002209844, Database accession no. L14938 * |
| DATABASE EMBL [online] XP002209845, Database accession no. AB007912 * |
| OKAZAKI TAKASHI ET AL: "Molecular diversity of the SCG10/stathmin gene family in the mouse.", GENOMICS, vol. 18, no. 2, 1993, pages 360 - 373, XP002209842, ISSN: 0888-7543 * |
| See also references of WO9857976A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998057976A1 (en) | 1998-12-23 |
| JP2002513294A (en) | 2002-05-08 |
| AU7970498A (en) | 1999-01-04 |
| CA2294569A1 (en) | 1998-12-23 |
| EP1003770A1 (en) | 2000-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6050898A (en) | Secreted proteins and polynucleotides encoding them | |
| AU6777298A (en) | Secreted proteins and polynucleotides encoding them | |
| AU6578398A (en) | Secreted proteins and polynucleotides encoding them | |
| AU3890797A (en) | Secreted proteins and polynucleotides encoding them | |
| AU7159898A (en) | Secreted proteins and polynucleotides encoding them | |
| AU7807298A (en) | Secreted proteins and polynucleotides encoding them | |
| AU6702298A (en) | Secreted proteins and polynucleotides encoding them | |
| AU1101199A (en) | Secreted proteins and polynucleotides encoding them | |
| AU7142498A (en) | Secreted proteins and polynucleotides encoding them | |
| EP1056764A4 (en) | Secreted proteins and polynucleotides encoding them | |
| AU1417899A (en) | Secreted proteins and polynucleotides encoding them | |
| EP1075487A4 (en) | Secreted proteins and polynucleotides encoding them | |
| AU6337398A (en) | Secreted proteins and polynucleotides encoding them | |
| AU5828398A (en) | Secreted proteins and polynucleotides encoding them | |
| AU6590898A (en) | Secreted proteins and polynucleotides encoding them | |
| EP1012261A4 (en) | Secreted proteins and polynucleotides encoding them | |
| AU5801998A (en) | Secreted proteins and polynucleotides encoding them | |
| AU6546898A (en) | Secreted proteins and polynucleotides encoding them | |
| EP1040118A4 (en) | Secreted proteins and polynucleotides encoding them | |
| AU7826498A (en) | Secreted proteins and polynucleotides encoding them | |
| EP1017719A4 (en) | Secreted proteins and polynucleotides encoding them | |
| AU6765098A (en) | Secreted proteins and polynucleotides encoding them | |
| EP1032652A4 (en) | Secreted proteins and polynucleotides encoding them | |
| AU6439598A (en) | Secreted proteins and polynucleotides encoding them | |
| AU1421499A (en) | Secreted proteins and polynucleotides encoding them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20000119 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HOWES, STEVEN, H. Inventor name: AGOSTINO, MICHAEL, J. Inventor name: SPAULDING, VIKKI Inventor name: TREACY, MAURICE Inventor name: RACIE, LISA, A. Inventor name: LAVALLIE, EDWARD, R. Inventor name: MCCOY, JOHN, M. Inventor name: JACOBS, KENNETH |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HOWES, STEVEN, H. Inventor name: AGOSTINO, MICHAEL, J. Inventor name: SPAULDING, VIKKI Inventor name: TREACY, MAURICE Inventor name: RACIE, LISA, A. Inventor name: LAVALLIE, EDWARD, R. Inventor name: MCCOY, JOHN, M. Inventor name: JACOBS, KENNETH |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GENETICS INSTITUTE, LLC |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20020916 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20030131 |